Found 3 results
Author Title [ Type(Asc)] Year
Filters: Author is Solomon, S  [Clear All Filters]
Journal Article
S. Solomon, Wittes, J., Finn, P. V., Fowler, R., Viner, J., Bertagnolli, M. M., Arber, N., Levin, B., Meinert, C. L., Martin, B., Pater, J. L., Goss, P. E., Lance, P., Obara, S., Chew, E., Kim, J., Arndt, G., Hawk, E., and Group, C. Trial Safe, “Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials The Cross Trial Safety Analysis”, Circulation, vol. 117, pp. 2104-2113, 2008.
Conference Paper
V. Ramanathan, Kumar, M., Mahalingam, J., Narayanan, P., Solomon, S., Boaz, M., Sayeed, E., Scharton-Kersten, T., Seth-Smith, M., Verlinde, C., Vooijs, D., Barin, B., Lombardo, A., Kochhar, S., Excler, J., and Fast, P., “A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
V. D. Ramanathan, Kumar, M., Jayashri, M., Sathyamoorthy, P., Narayanan, P. R., Solomon, S., Cox, J., Sayeed, E., Ackland, J., Verlinde, C., Vooijs, D., Loughran, K., Barin, B., Lombardo, A., Gilmour, J., Stevens, G., Kochhar, S., Excler, J., and Fast, P., “A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara (rMVA) Virus Preventive Multigenic HIV Subtype C Vaccine (TBC-M4) in Indian Volunteers”, in Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms, Bangkok, Thailand, 2008.